BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6170209)

  • 1. Concentration of substance P-like immunoreactivity (SPLI) in tissues of dog, rat and mouse.
    Brodin E; Nilsson G
    Acta Physiol Scand; 1981 Jul; 112(3):305-12. PubMed ID: 6170209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue concentration and release of substance P-like immunoreactivity in the dental pulp.
    Brodin E; Gazelius B; Olgart L; Nilsson G
    Acta Physiol Scand; 1981 Feb; 111(2):141-9. PubMed ID: 6169251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regional distribution of kassinin-like immunoreactivity in central and peripheral tissues of the cat.
    Hunter JC; Hannah PA; Maggio JE
    Brain Res; 1985 Aug; 341(2):228-32. PubMed ID: 2412635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of substance P-like immunoreactivity and tachykinin-encoding mRNAs in rat medullary thyroid carcinoma cell lines.
    Cremins JD; Michel J; Farah JM; Krause JE
    J Neurochem; 1992 Mar; 58(3):817-25. PubMed ID: 1371148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity in Limulus: III. Morphological and biochemical studies of FMRFamide-like immunoreactivity and colocalized substance P-like immunoreactivity in the brain and lateral eye.
    Lewandowski TJ; Lehman HK; Chamberlain SC
    J Comp Neurol; 1989 Oct; 288(1):136-53. PubMed ID: 2477411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical characterization of substance P-like immunoreactivity in primary afferent neurones.
    Harmar A; Keen P
    Brain Res; 1981 Sep; 220(1):203-7. PubMed ID: 6168332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of substance-P-like immunoreactivity in dog paw lymph after scalding injury.
    Jonsson CE; Brodin E; Dalsgaard CJ; Haegerstrand A
    Acta Physiol Scand; 1986 Jan; 126(1):21-4. PubMed ID: 2420151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P and catecholaminergic expression in neurons of the hamster main olfactory bulb.
    Kream RM; Davis BJ; Kawano T; Margolis FL; Macrides F
    J Comp Neurol; 1984 Jan; 222(1):140-54. PubMed ID: 6199381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of pregnancy and parturition on the substance P content of the rat uterus: uterine growth is accompanied by hypertrophy of its afferent innervation.
    Amira S; Morrison JF; Rayfield KM
    Exp Physiol; 1995 Jul; 80(4):645-50. PubMed ID: 7576603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay measurement of substance P release following a meat meal.
    Akande B; Reilly P; Modlin IM; Jaffe BM
    Surgery; 1981 Mar; 89(3):378-83. PubMed ID: 6162204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P and its metabolites in normal human tears.
    Yamada M; Ogata M; Kawai M; Mashima Y; Nishida T
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2622-5. PubMed ID: 12147594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of substance P-like immunoreactivity in the cat dental pulp by antidromic nerve stimulation.
    Gazelius B; Brodin E; Olgart L
    Acta Physiol Scand; 1981 Mar; 111(3):319-27. PubMed ID: 6171998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromedin U--a study of its distribution in the rat.
    Domin J; Ghatei MA; Chohan P; Bloom SR
    Peptides; 1987; 8(5):779-84. PubMed ID: 3432125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prenatal development of substance P and enkephalin-containing neurons in the rat.
    Pickel VM; Sumal KK; Miller RJ
    J Comp Neurol; 1982 Oct; 210(4):411-22. PubMed ID: 6183298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
    Menkes CJ; Renoux M; Laoussadi S; Mauborgne A; Bruxelle J; Cesselin F
    J Rheumatol; 1993 Apr; 20(4):714-7. PubMed ID: 7684449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A technique for decalcification and demonstration of substance P-like immunoreactivity.
    Wakisaka S; Ichikawa H; Nishimoto T; Matsuo S; Yamamoto K; Nakata T; Akai M
    Stain Technol; 1986 Jan; 61(1):39-42. PubMed ID: 2420039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of substance P-like immunoreactivity in Xenopus embryos.
    Gallagher BC; Moody SA
    J Comp Neurol; 1987 Jun; 260(2):175-85. PubMed ID: 2440913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory peptides in the heart and major vessels of man and mammals.
    Onuoha GN; Nicholls DP; Alpar EK; Ritchie A; Shaw C; Buchanan K
    Neuropeptides; 1999 Apr; 33(2):165-72. PubMed ID: 10657487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of substance P and methionine-enkephalin in salivary glands and effect of chronic morphine treatment on levels of these peptides.
    Yonehara N; Tsai HY; Chen JQ; Inoki R
    Jpn J Pharmacol; 1989 Aug; 50(4):503-6. PubMed ID: 2476579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of substance P-like immunoreactivity in the goldfish brain.
    Sharma SC; Berthoud VM; Breckwoldt R
    J Comp Neurol; 1989 Jan; 279(1):104-16. PubMed ID: 2464008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.